Study for treatment of newly diagnosed multiple myeloma
Primary disease category: Cancer
Secondary disease categories: Myeloma
Sponsor: Millennium Pharmaceuticals
Projected enrollment dates: January 2014 to June 2018
Official study title: A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma
External link(s):
UA Cancer Center Website
ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/NCT01850524